George Thom
Director AstraZeneca
Working at AstraZeneca for 25 years with experience in protein engineering and RNA Therapies. As part of a team successfully isolated, optimised and developed various antibodies to the clinic and market. Also, helped deliver mRNA based vaccines into the clinic. I’m currently working on multiple mRNA based therapeutics in different therapeutic areas for treatment of disease to improve patients lives.
Seminars
Tuesday 21st July 2026
Engineering Next Generation mRNA-Based Therapeutic Proteins to Advance Infectious & Rare Disease Therapy Portfolios
11:00 am
- Providing an overview of the mRNA platform
- Case Study Presentation: mRNA encoded IgGs/VHHs for the treatment of infectious diseases
- Case Study Presentation: Engineering next generation cas9 proteins to advance rare disease therapies
